Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Search for other papers by Wentao Zhou in
Google Scholar
PubMed
Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Wenqi Chen in
Google Scholar
PubMed
Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
the two groups (Supplementary Fig. 2). Then, we assessed the values of the markers in predicting RFS among all surgically resected pNEN patients. The results from the X-tile software showed that only NLR, LMR and lymphocyte count could be used as
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
Search for other papers by Tiina Vesterinen in
Google Scholar
PubMed
Search for other papers by Teijo Kuopio in
Google Scholar
PubMed
Search for other papers by Maarit Ahtiainen in
Google Scholar
PubMed
Search for other papers by Aija Knuuttila in
Google Scholar
PubMed
Search for other papers by Harri Mustonen in
Google Scholar
PubMed
Search for other papers by Kaisa Salmenkivi in
Google Scholar
PubMed
Search for other papers by Johanna Arola in
Google Scholar
PubMed
Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Search for other papers by Caj Haglund in
Google Scholar
PubMed
behave much more aggressively. As proposed in a recent paper, PCs should be studied independently of LCNEC and SCLC ( 22 ). Thus, we collected a large, retrospective, and clinically well-characterized series of surgically resected PC tumors to investigate
Search for other papers by Aida Javanbakht in
Google Scholar
PubMed
Search for other papers by Massimo D’Apuzzo in
Google Scholar
PubMed
Search for other papers by Behnam Badie in
Google Scholar
PubMed
Search for other papers by Behrouz Salehian in
Google Scholar
PubMed
intracranial metastases are in the pituitary ( 89 , 141 ). It has been estimated that 1.8% of all surgically resected pituitary masses are metastases ( 6 ). The incidence of Pit Met is independent of gender, and most patients were in sixth decades of life
Search for other papers by Adrian F Daly in
Google Scholar
PubMed
Search for other papers by David A Cano in
Google Scholar
PubMed
Search for other papers by Eva Venegas-Moreno in
Google Scholar
PubMed
Search for other papers by Patrick Petrossians in
Google Scholar
PubMed
Search for other papers by Elena Dios in
Google Scholar
PubMed
Search for other papers by Emilie Castermans in
Google Scholar
PubMed
Search for other papers by Alvaro Flores-Martínez in
Google Scholar
PubMed
Search for other papers by Vincent Bours in
Google Scholar
PubMed
Search for other papers by Albert Beckers in
Google Scholar
PubMed
Search for other papers by Alfonso Soto-Moreno in
Google Scholar
PubMed
immunohistochemical score in surgically-resected somatotropinomas may be a good indicator of whether patients are SST2-specific SSA responders ( 15 , 16 ). Screening studies in the general clinical population of pituitary adenomas are not particularly useful as
Search for other papers by Jan Kvasnička in
Google Scholar
PubMed
Search for other papers by Ondřej Petrák in
Google Scholar
PubMed
Search for other papers by Tomáš Zelinka in
Google Scholar
PubMed
Search for other papers by Judita Klímová in
Google Scholar
PubMed
Search for other papers by Barbora Kološová in
Google Scholar
PubMed
Search for other papers by Květoslav Novák in
Google Scholar
PubMed
Search for other papers by David Michalský in
Google Scholar
PubMed
Search for other papers by Jiří Widimský Jr in
Google Scholar
PubMed
Search for other papers by Robert Holaj in
Google Scholar
PubMed
Cardiology 2009 103 411 – 415 . ( https://doi.org/10.1016/j.amjcard.2008.09.102 ) 13 Lee SH Park JH Lee JY Lee SR Rhee KS Chae JK Kim WH Sul JY Oh JK Kwon HJ Clinical profiles of patients with surgically resected pheochromocytoma and
Diagnósticos da América SA, Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Paula Bruna Araujo in
Google Scholar
PubMed
Neuroendocrinology Unit, Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Rio de Janeiro, Brazil
Endocrinology Unit, Hospital Federal de Bonsucesso, Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Leandro Kasuki in
Google Scholar
PubMed
Search for other papers by Carlos Henrique de Azeredo Lima in
Google Scholar
PubMed
Search for other papers by Liana Ogino in
Google Scholar
PubMed
National Cancer Institute, Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Aline H S Camacho in
Google Scholar
PubMed
Search for other papers by Leila Chimelli in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Molecular Genetics Laboratory, Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Rio de Janeiro, Brazil
Neuroendocrinology Unit, Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Monica R Gadelha in
Google Scholar
PubMed
’s disease was diagnosed in this male patient at the age of 15 years. He had a 10 mm pituitary adenoma that was surgically resected four times, with immunohistochemistry positive for adrenocorticotrophic hormone (ACTH) and a Ki-67 index of 5%. As the patient
Search for other papers by Sara Ahmadi in
Google Scholar
PubMed
Search for other papers by Iñigo Landa in
Google Scholar
PubMed
surgically resected nodules that harbored an EIF1AX mutation and showed that every single thyroid specimen with coexisting EIF1AX + RAS mutations was a carcinoma ( 65 ). Overall, there is growing evidence suggesting that, although RAS or EIF1AX